Clinical trial
Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine…
NCT00004386 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Terminated
Key facts
| NCT number | NCT00004386 |
|---|---|
| Title | Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | Children's National Research Institute |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ornithine Transcarbamylase Deficiency Disease |
| Intervention type | Genetic |
| Interventions | recombinant adenovirus containing the ornithine transcarbamylase gene |
| Start date | Oct 1, 1995 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: